%PDF- %PDF-
Direktori : /var/www/html/shaban/duassis/api/public/storage/xwqtu/cache/ |
Current File : //var/www/html/shaban/duassis/api/public/storage/xwqtu/cache/8a6551d17cda35132838b6235cdea89e |
a:5:{s:8:"template";s:9437:"<!DOCTYPE html> <html lang="en"> <head> <meta charset="utf-8"/> <meta content="width=device-width, initial-scale=1.0" name="viewport"/> <title>{{ keyword }}</title> <link href="//fonts.googleapis.com/css?family=Open+Sans%3A300%2C400%2C600%2C700%2C800%7CRoboto%3A100%2C300%2C400%2C500%2C600%2C700%2C900%7CRaleway%3A600%7Citalic&subset=latin%2Clatin-ext" id="quality-fonts-css" media="all" rel="stylesheet" type="text/css"/> <style rel="stylesheet" type="text/css"> html{font-family:sans-serif;-webkit-text-size-adjust:100%;-ms-text-size-adjust:100%}body{margin:0}footer,nav{display:block}a{background:0 0}a:active,a:hover{outline:0}@media print{*{color:#000!important;text-shadow:none!important;background:0 0!important;box-shadow:none!important}a,a:visited{text-decoration:underline}a[href]:after{content:" (" attr(href) ")"}a[href^="#"]:after{content:""}p{orphans:3;widows:3}.navbar{display:none}}*{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}:after,:before{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}html{font-size:62.5%;-webkit-tap-highlight-color:transparent}body{font-family:"Helvetica Neue",Helvetica,Arial,sans-serif;font-size:14px;line-height:1.42857143;color:#333;background-color:#fff}a{color:#428bca;text-decoration:none}a:focus,a:hover{color:#2a6496;text-decoration:underline}a:focus{outline:thin dotted;outline:5px auto -webkit-focus-ring-color;outline-offset:-2px}p{margin:0 0 10px}ul{margin-top:0;margin-bottom:10px}.container{padding-right:15px;padding-left:15px;margin-right:auto;margin-left:auto}@media (min-width:768px){.container{width:750px}}@media (min-width:992px){.container{width:970px}}@media (min-width:1200px){.container{width:1170px}}.container-fluid{padding-right:15px;padding-left:15px;margin-right:auto;margin-left:auto}.row{margin-right:-15px;margin-left:-15px}.col-md-12{position:relative;min-height:1px;padding-right:15px;padding-left:15px}@media (min-width:992px){.col-md-12{float:left}.col-md-12{width:100%}}.collapse{display:none} .nav{padding-left:0;margin-bottom:0;list-style:none}.nav>li{position:relative;display:block}.nav>li>a{position:relative;display:block;padding:10px 15px}.nav>li>a:focus,.nav>li>a:hover{text-decoration:none;background-color:#eee}.navbar{position:relative;min-height:50px;margin-bottom:20px;border:1px solid transparent}@media (min-width:768px){.navbar{border-radius:4px}}@media (min-width:768px){.navbar-header{float:left}}.navbar-collapse{max-height:340px;padding-right:15px;padding-left:15px;overflow-x:visible;-webkit-overflow-scrolling:touch;border-top:1px solid transparent;box-shadow:inset 0 1px 0 rgba(255,255,255,.1)}@media (min-width:768px){.navbar-collapse{width:auto;border-top:0;box-shadow:none}.navbar-collapse.collapse{display:block!important;height:auto!important;padding-bottom:0;overflow:visible!important}}.container-fluid>.navbar-collapse,.container-fluid>.navbar-header{margin-right:-15px;margin-left:-15px}@media (min-width:768px){.container-fluid>.navbar-collapse,.container-fluid>.navbar-header{margin-right:0;margin-left:0}}.navbar-brand{float:left;height:50px;padding:15px 15px;font-size:18px;line-height:20px}.navbar-brand:focus,.navbar-brand:hover{text-decoration:none}@media (min-width:768px){.navbar>.container-fluid .navbar-brand{margin-left:-15px}}.navbar-nav{margin:7.5px -15px}.navbar-nav>li>a{padding-top:10px;padding-bottom:10px;line-height:20px}@media (min-width:768px){.navbar-nav{float:left;margin:0}.navbar-nav>li{float:left}.navbar-nav>li>a{padding-top:15px;padding-bottom:15px}.navbar-nav.navbar-right:last-child{margin-right:-15px}}@media (min-width:768px){.navbar-right{float:right!important}}.clearfix:after,.clearfix:before,.container-fluid:after,.container-fluid:before,.container:after,.container:before,.nav:after,.nav:before,.navbar-collapse:after,.navbar-collapse:before,.navbar-header:after,.navbar-header:before,.navbar:after,.navbar:before,.row:after,.row:before{display:table;content:" "}.clearfix:after,.container-fluid:after,.container:after,.nav:after,.navbar-collapse:after,.navbar-header:after,.navbar:after,.row:after{clear:both}@-ms-viewport{width:device-width}html{font-size:14px;overflow-y:scroll;overflow-x:hidden;-ms-overflow-style:scrollbar}@media(min-width:60em){html{font-size:16px}}body{background:#fff;color:#6a6a6a;font-family:"Open Sans",Helvetica,Arial,sans-serif;font-size:1rem;line-height:1.5;font-weight:400;padding:0;background-attachment:fixed;text-rendering:optimizeLegibility;overflow-x:hidden;transition:.5s ease all}p{line-height:1.7;margin:0 0 25px}p:last-child{margin:0}a{transition:all .3s ease 0s}a:focus,a:hover{color:#121212;outline:0;text-decoration:none}.padding-0{padding-left:0;padding-right:0}ul{font-weight:400;margin:0 0 25px 0;padding-left:18px}ul{list-style:disc}ul>li{margin:0;padding:.5rem 0;border:none}ul li:last-child{padding-bottom:0}.site-footer{background-color:#1a1a1a;margin:0;padding:0;width:100%;font-size:.938rem}.site-info{border-top:1px solid rgba(255,255,255,.1);padding:30px 0;text-align:center}.site-info p{color:#adadad;margin:0;padding:0}.navbar-custom .navbar-brand{padding:25px 10px 16px 0}.navbar-custom .navbar-nav>li>a:focus,.navbar-custom .navbar-nav>li>a:hover{color:#f8504b}a{color:#f8504b}.navbar-custom{background-color:transparent;border:0;border-radius:0;z-index:1000;font-size:1rem;transition:background,padding .4s ease-in-out 0s;margin:0;min-height:100px}.navbar a{transition:color 125ms ease-in-out 0s}.navbar-custom .navbar-brand{letter-spacing:1px;font-weight:600;font-size:2rem;line-height:1.5;color:#121213;margin-left:0!important;height:auto;padding:26px 30px 26px 15px}@media (min-width:768px){.navbar-custom .navbar-brand{padding:26px 10px 26px 0}}.navbar-custom .navbar-nav li{margin:0 10px;padding:0}.navbar-custom .navbar-nav li>a{position:relative;color:#121213;font-weight:600;font-size:1rem;line-height:1.4;padding:40px 15px 40px 15px;transition:all .35s ease}.navbar-custom .navbar-nav>li>a:focus,.navbar-custom .navbar-nav>li>a:hover{background:0 0}@media (max-width:991px){.navbar-custom .navbar-nav{letter-spacing:0;margin-top:1px}.navbar-custom .navbar-nav li{margin:0 20px;padding:0}.navbar-custom .navbar-nav li>a{color:#bbb;padding:12px 0 12px 0}.navbar-custom .navbar-nav>li>a:focus,.navbar-custom .navbar-nav>li>a:hover{background:0 0;color:#fff}.navbar-custom li a{border-bottom:1px solid rgba(73,71,71,.3)!important}.navbar-header{float:none}.navbar-collapse{border-top:1px solid transparent;box-shadow:inset 0 1px 0 rgba(255,255,255,.1)}.navbar-collapse.collapse{display:none!important}.navbar-custom .navbar-nav{background-color:#1a1a1a;float:none!important;margin:0!important}.navbar-custom .navbar-nav>li{float:none}.navbar-header{padding:0 130px}.navbar-collapse{padding-right:0;padding-left:0}}@media (max-width:768px){.navbar-header{padding:0 15px}.navbar-collapse{padding-right:15px;padding-left:15px}}@media (max-width:500px){.navbar-custom .navbar-brand{float:none;display:block;text-align:center;padding:25px 15px 12px 15px}}@media (min-width:992px){.navbar-custom .container-fluid{width:970px;padding-right:15px;padding-left:15px;margin-right:auto;margin-left:auto}}@media (min-width:1200px){.navbar-custom .container-fluid{width:1170px;padding-right:15px;padding-left:15px;margin-right:auto;margin-left:auto}} @font-face{font-family:'Open Sans';font-style:normal;font-weight:300;src:local('Open Sans Light'),local('OpenSans-Light'),url(http://fonts.gstatic.com/s/opensans/v17/mem5YaGs126MiZpBA-UN_r8OXOhs.ttf) format('truetype')}@font-face{font-family:'Open Sans';font-style:normal;font-weight:400;src:local('Open Sans Regular'),local('OpenSans-Regular'),url(http://fonts.gstatic.com/s/opensans/v17/mem8YaGs126MiZpBA-UFW50e.ttf) format('truetype')} @font-face{font-family:Roboto;font-style:normal;font-weight:700;src:local('Roboto Bold'),local('Roboto-Bold'),url(http://fonts.gstatic.com/s/roboto/v20/KFOlCnqEu92Fr1MmWUlfChc9.ttf) format('truetype')}@font-face{font-family:Roboto;font-style:normal;font-weight:900;src:local('Roboto Black'),local('Roboto-Black'),url(http://fonts.gstatic.com/s/roboto/v20/KFOlCnqEu92Fr1MmYUtfChc9.ttf) format('truetype')} </style> </head> <body class=""> <nav class="navbar navbar-custom" role="navigation"> <div class="container-fluid padding-0"> <div class="navbar-header"> <a class="navbar-brand" href="#"> {{ keyword }} </a> </div> <div class="collapse navbar-collapse" id="custom-collapse"> <ul class="nav navbar-nav navbar-right" id="menu-menu-principale"><li class="menu-item menu-item-type-post_type menu-item-object-post menu-item-169" id="menu-item-169"><a href="#">About</a></li> <li class="menu-item menu-item-type-post_type menu-item-object-post menu-item-121" id="menu-item-121"><a href="#">Location</a></li> <li class="menu-item menu-item-type-post_type menu-item-object-post menu-item-120" id="menu-item-120"><a href="#">Menu</a></li> <li class="menu-item menu-item-type-post_type menu-item-object-post menu-item-119" id="menu-item-119"><a href="#">FAQ</a></li> <li class="menu-item menu-item-type-post_type menu-item-object-post menu-item-122" id="menu-item-122"><a href="#">Contacts</a></li> </ul> </div> </div> </nav> <div class="clearfix"></div> {{ text }} <br> {{ links }} <footer class="site-footer"> <div class="container"> <div class="row"> <div class="col-md-12"> <div class="site-info"> <p>{{ keyword }} 2021</p></div> </div> </div> </div> </footer> </body> </html>";s:4:"text";s:16773:"The company reported ($0.58) […] June 14, 2021 - The year-to-date (YTD) return or performance of Applied Molecular (AMTI) is up 60.25% and is outperforming the overall stock market by 46.84%. The following slide deck was published by Applied Molecular Transport Inc. Read more on seekingalpha.com. Distributed by Public, unedited and unaltered, on 13 May 2021 20:35:05 UTC. The Company is leveraging its technology platform to design and develop a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Latest Trade: $47.94 0.00 (0.0%) First … The company report on April 1, 2021 that Applied Molecular Transport Announces Pricing of Public Offering of Common Stock. Applied Molecular Transport Inc. (NASDAQ:AMTI) shareholders (or potential shareholders) will be happy to see that the Independent Director, David Lamond, recently bought a whopping US$1.1m worth of stock, at a price of US$42.00.While that only increased their holding size by 2.5%, it is still a big swing by our standards. Historical daily share price chart and data for Applied Molecular Transport since 2021 adjusted for splits. Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a … Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Applied Molecular Transport Inc. published this content on 13 May 2021 and is solely responsible for the information contained therein. What's new Vimeo Record: video messaging for teams Vimeo Create: quick and easy video-maker Get started for free Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to … Day's Range: $46.66 - $49.50. Applied Molecular Transport has raised a total of $177.9M in funding over 3 rounds. Compare pay for popular roles and read about the team’s work-life balance. Applied Molecular Transport is seeking a talented and highly motivated Sr. Research Associate/Associate Scientist to join our biology team to support efforts towards the … Seeking Alpha • 14h. Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Applied Molecular Transport Inc is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Applied Molecular Transport Inc. Common Stock, also called Applied Molecular Transport, is a clinical-stage biopharmaceutical company, which engages in the design and development of a pipeline of novel oral biologic product candidates for the treatment of autoimmune, inflammatory, and metabolic diseases. GlobeNewswire. Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a … Upright in the green during last session for gaining 3.69%, in the last five days AMTI remained trading in the green while hitting it’s week-highest on Monday, Apr 12 when the stock touched $48.92- price level, adding 14.47% to its value on the day. Applied Molecular Transport (AMT) is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Applied Molecular Transport. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. Applied Molecular Transport Expands Clinical Pipeline And Announces First Subject Dosed In Phase 1A Trial Of Oral AMT-126. 46 mins Applied Molecular Transport Inc. (AMTI) Fell Out Of Favor With Hedge Funds Insider Monkey . Their stock opened with $14.00 in its Jun 4, 2020 IPO. Applied Molecular Transport Inc. (US:AMTI) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a … Applied Molecular Transport Inc. (NASDAQ:AMTI) saw an uptick in trading volume on Thursday after the company announced better than expected quarterly earnings. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. AppliedMolecularTrans shows improving price performance, earning an upgrade to its IBD Relative Strength Rating. Applied Molecular Transport Inc. ( NASDAQ:AMTI ) shareholders (or potential shareholders) will be happy to see that the... The latest closing stock price for Applied Molecular Transport as of May 28, 2021 is 47.94.. Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a … 3/31/2021. The option you choose will be based on your location and preference. Applied Molecular Transport Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update Provided by GlobeNewswire Mar 19, 2021 8:05 PM UTC GlobeNewswire Commence buying Applied Molecular Transport Inc. by depositing fiat currencies, like USD or EUR. News for Applied Molecular Transport Inc. Tuesday, June 30, 2020. Applied Molecular Transport stock has risen more than 5% past a 36.31 entry in a first-stage consolidation, meaning it's now out of a proper buy range. Applied Molecular Transport is seeking a talented and highly motivated Sr. Research Associate/Associate Scientist to join our biology team to support efforts … Plus Applied Molecular Transport has granted the underwriters a 30-day option to buy up to an additional 375,000 shares of its common stock at the public offering price, less the underwriting discounts and commissions. Employer Identification No.) APPLIED MOLECULAR TRANSPORT INC. (Exact name of Registrant as specified in its Charter) Delaware 81-4481426 (State or other jurisdiction of incorporation or organization) (I.R.S. It design and develop a pipeline of novel oral biologic product candidates to treat … Applied Molecular Transport Inc. [NASDAQ: AMTI] stock went on an upward path that rose over 44.44% on Thursday, amounting to a one-week price increase of more than 32.22%. Applied Molecular Transport (AMTI) has filed to raise $100 million in an IPO, according to an S-1 registration statement. About Applied Molecular Transport, Inc. (adapted from Applied Molecular Transport, Inc. prospectus): They are a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Current Price: $47.41. AMT’s proprietary technology platform allows it to exploit existing natural Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced the pricing of an underwritten public offering of 2,500,000 shares of its common stock at a public offering price of $42.00 per share Applied Molecular Transport is developing biologic drugs that use a cell’s own mechanisms to get a therapy to a target and the biotech is now … Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company. Applied Molecular Transport is funded by 2 investors. SOUTH SAN FRANCISCO, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood, Ph.D., chief executive officer and co-founder, will participate in a fireside chat during the BofA Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Regulatory Affairs at AMT is a small group taking on the large task of…. Applied Molecular Transport Priced, Nasdaq: AMTI. Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The Company is leveraging its technology platform to design and develop a pipeline of oral biologic product candidates to treat autoimmune, infla mmatory, metabolic, and other diseases. Applied Molecular Transport prices equity offering at $42 Applied Molecular Transport proposes 2.5M stock offering Applied Molecular Transport EPS beats by $0.38 Applied Molecular Transport started at outperform with $32 stock price target at SVB Leerink MarketWatch. 52wk Range: Our Proprietary Technology Platform Is an Engine for the Design of Novel Oral Biologic Therapeutics 07:20 AM ET Applied Molecular Transport Inc is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a … Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of September. Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat … Monday, June 01, 2020. About Applied Molecular Transport Inc Applied Molecular Transport Inc. operates as a biotech company. Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a … Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a … Applied Molecular Transport revenue from 2019 to 2021. Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a … Applied Molecular Transport General Information Description. Associate Director/Director, Regulatory CMC. Polymer-based nanodielectric materials were developed employing uniaxially oriented disentangled ultra-high molecular weight polyethylene (dis … It officially launched in September 2019, having raised … Applied Molecular Transport Inc, a clinical-stage biopharmaceutical company, engages in the development of a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Key Data Points. Funding your account with fiat currencies, like USD or EUR for swaping can be done different ways, which includes domestic wire transfers, SWIFT and SEPA or debitcard. Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a … View the latest Applied Molecular Transport Inc. (AMTI) stock price, news, historical charts, analyst ratings and financial information from WSJ. Primary metrics and data points about Applied Molecular Transport Inc.. Market Cap: $2B. Their stock opened with $14.00 in its Jun 4, 2020 IPO. Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Applied Molecular Transport Inc. (NASDAQ:AMTI) was in 3 hedge funds' portfolios at the end of the first quarter of 2021. Their latest funding was raised on Mar 31, 2021 from a Post-IPO Equity round. San Francisco, CA. Report this profile Activity Sometimes all it takes is one visionary to turn an idea into something real. About Applied Molecular Transport Inc. Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company. (AMTI) raised $130 million in an IPO on Friday, June 5th 2020. The company issued 10,000,000 shares at $12.00-$14.00 per share. BofA Securities, Jefferies and SVB Leerink served as the underwriters for the IPO. What is Applied Molecular Transport's stock symbol? Applied Molecular Transport trades on the NASDAQ under the ticker symbol "AMTI." Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected. AppliedMolecularTrans shows improving price performance, earning an upgrade to its IBD Relative Strength Rating. Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to … About Applied Molecular Transport Inc. Phase 1 biotech developing novel oral therapies for inflammatory diseases. Print. Applied Molecular Transport Inc. (NASDAQ:AMTI) trade information. 17 days ago. Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Applied Molecular Transport (AMT) is a privately held venture-backed, clinical-stage biopharmaceutical company that is applying its proprietary bioengineering technology platform to create transformative oral biological therapies for patients with severe autoimmune, inflammatory, liver and metabolic diseases. Learn More General Information: Business: We are a clinical-stage biopharmaceutical company leveraging our proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Applied Molecular Transport Announces Pricing of Public Offering of Common Stock. APPLIED MOLECULAR TRANSPORT. BA/BS degree in life sciences, chemistry, molecular biology, immunology or similar. Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company. About Applied Molecular Transport Inc.Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to … Applied Molecular Transport is a development-stage company with a novel platform technology enabling oral delivery of therapeutic biologic products. We are looking for a new team member who is excited about translating this technical advance into new medicinal products. Applied Molecular Transport is registered under the ticker NASDAQ:AMTI . 07:25 AM ET. Applied Molecular Transport Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Applied Molecular Transport was incorporated in 2010, but its current iteration came to be in 2016. More Details 9,151 shares traded hands during trading, a decline of 96% from the previous session’s volume of 228,361 shares.The stock last traded at $42.07 and had previously closed at $44.96. ";s:7:"keyword";s:27:"applied molecular transport";s:5:"links";s:1075:"<a href="https://api.duassis.com/storage/xwqtu/cabin-in-the-woods-for-sale-near-me">Cabin In The Woods For Sale Near Me</a>, <a href="https://api.duassis.com/storage/xwqtu/rodrigues-family-on-the-view">Rodrigues Family On The View</a>, <a href="https://api.duassis.com/storage/xwqtu/adcc-2019-brackets-results">Adcc 2019 Brackets Results</a>, <a href="https://api.duassis.com/storage/xwqtu/st-john-fisher-college-nursing">St John Fisher College Nursing</a>, <a href="https://api.duassis.com/storage/xwqtu/social-media-during-the-pandemic">Social Media During The Pandemic</a>, <a href="https://api.duassis.com/storage/xwqtu/emergency-hq-cheats-for-android">Emergency Hq Cheats For Android</a>, <a href="https://api.duassis.com/storage/xwqtu/ice-skating-lessons-nyc-adults">Ice Skating Lessons Nyc Adults</a>, <a href="https://api.duassis.com/storage/xwqtu/liquid-glass-polish-vs-ceramic-coating">Liquid Glass Polish Vs Ceramic Coating</a>, <a href="https://api.duassis.com/storage/xwqtu/thousand-island-dressing-nutrition-label">Thousand Island Dressing Nutrition Label</a>, ";s:7:"expired";i:-1;}